Search in:

Gynecological Endocrinology Volume 29, 2013 - Issue 3

Submit an article Journal homepage

424

Views

CrossRef citations to date

Altmetric

Polycistic Ovary

Effects of metformin on serum insulin and anti-mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome

Areana Diogo NascimentoSexual Medicine Service, Department of Gynaecology and Obstetrics, Faculty of Medicine of Ribeirão Preto, São Paulo University, Ribeirão Preto, Brazil

Lucia Alves Silva LaraSexual Medicine Service, Department of Gynaecology and Obstetrics, Faculty of Medicine of Ribeirão Preto, São Paulo University, Ribeirão Preto, Brazil

Ana Carolina Japur de Sá Rosa-e-SilvaSexual Medicine Service, Department of Gynaecology and Obstetrics, Faculty of Medicine of Ribeirão Preto, São Paulo University, Ribeirão Preto, Brazil

Rui Alberto FerrianiSector of Human Reproduction, Department of Gynaecology and Obstetrics, Faculty of Medicine of Ribeirão Preto, São Paulo University, Ribeirão Preto, Brazil

Rosana Maria ReisSector of Human Reproduction, Department of Gynaecology and Obstetrics, Faculty of Medicine of Ribeirão Preto, São Paulo University, Ribeirão Preto, BrazilCorrespondence[email protected]

Pages 246-249 | Received 04 Sep 2012, Accepted 24 Sep 2012, Published online: 30 Nov 2012

Cite this article
https://doi.org/10.3109/09513590.2012.736563

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (19)

Sevgi Ayhan, Necati Hancerliogullari, Gurhan Guney, Murat Gozukucuk, Muzaffer Caydere, Sergul Selvi Guney, Aytekin Tokmak & Yusuf Ustun. (2023) Does the addition of metformin to carboplatin treatment decreases ovarian reserve damage associated with carboplatin usage?. Journal of Ovarian Research 16:1.
Crossref

Lidia Rosi Medeiros, Tamy Colonetti, Erickson Cardoso Nagib, Maria Laura Rodrigues Uggioni, João Carlos Denoni Junior, Luciane Ceretta, Antonio José Grande & Maria Inês Rosa. (2023) Anti-Müllerian Hormone levels after metformin treatment in polycystic ovary syndrome: A systematic review and meta-analysis. Obesity Research & Clinical Practice 17:4, pages 288-297.
Crossref

Zhijiao Zhou, Hongzhi Chen, Ling Chu, Qiong Zou, Qian Chen, Jun Yang, Yang Liu & Xiang Ou. (2023) The effects of metformin on anti-Müllerian hormone levels in patients with polycystic ovary syndrome: a systematic review and meta-analysis. Journal of Ovarian Research 16:1.
Crossref

Wei-Wei Yin, Chang-Chang Huang, Yi-Ru Chen, Dan-Qing Yu, Min Jin & Chun Feng. (2022) The effect of medication on serum anti-müllerian hormone (AMH) levels in women of reproductive age: a meta-analysis. BMC Endocrine Disorders 22:1.
Crossref

V. Soldat-Stanković, S. Popović-Pejičić, S. Stanković, A. Prtina, G. Malešević, J. Bjekić-Macut, S. Livadas, S. Ognjanović, G. Mastorakos, D. Micić & D. Macut. (2021) The effect of metformin and myoinositol on metabolic outcomes in women with polycystic ovary syndrome: role of body mass and adiponectin in a randomized controlled trial. Journal of Endocrinological Investigation 45:3, pages 583-595.
Crossref

Dalal Kojok, Ghina Ghazeeri & Johnny T. Awwad. 2022. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome 233 253 .

Alexander O. Shpakov. (2021) Improvement Effect of Metformin on Female and Male Reproduction in Endocrine Pathologies and Its Mechanisms. Pharmaceuticals 14:1, pages 42.
Crossref

Chuan Xing, Chunzhu Li & Bing He. (2020) Insulin Sensitizers for Improving the Endocrine and Metabolic Profile in Overweight Women With PCOS. The Journal of Clinical Endocrinology & Metabolism 105:9, pages 2950-2963.
Crossref

Sydney K Willis, Lauren A Wise, Amelia K Wesselink, Kenneth J Rothman, Ellen M Mikkelsen, Katherine L Tucker, Ellen Trolle & Elizabeth E Hatch. (2020) Glycemic load, dietary fiber, and added sugar and fecundability in 2 preconception cohorts. The American Journal of Clinical Nutrition 112:1, pages 27-38.
Crossref

Albert Carrasco, Mónica P. Recabarren, Pedro P. Rojas-García, Mario Gutiérrez, Karina Morales, Teresa Sir-Petermann & Sergio E. Recabarren. (2020) Prenatal Testosterone Exposure Disrupts Insulin Secretion And Promotes Insulin Resistance. Scientific Reports 10:1.
Crossref

Agathe Dumont, Geoffroy Robin, Sophie Catteau-Jonard & Didier Dewailly. (2015) Role of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a review. Reproductive Biology and Endocrinology 13:1.
Crossref

Amr Mohamed S. Abdel Hamid, Wael A. Ismail Madkour & Tamer F. Borg. (2015) Inositol versus Metformin administration in polycystic ovary syndrome patients. Evidence Based Womenʼs Health Journal 5:3, pages 93-98.
Crossref

Helen N. Madsen, Finn F. Lauszus, Birgitta Trolle, Hans J. Ingerslev & Niels Tørring. (2015) Impact of metformin on anti‐Müllerian hormone in women with polycystic ovary syndrome: a secondary analysis of a randomized controlled trial. Acta Obstetricia et Gynecologica Scandinavica 94:5, pages 547-551.
Crossref

Amr Mohamed S. Abdelhamid, Wael A. Ismail Madkour & Tamer Farouk Borg. (2015) Inositol versus metformin administration in polycystic ovarian disease patients. Evidence Based Womenʼs Health Journal 5:2, pages 61-66.
Crossref

Ioannis E. Messinis, Christina I. Messini, George Anifandis & Konstantinos Dafopoulos. (2015) Polycystic ovaries and obesity. Best Practice & Research Clinical Obstetrics & Gynaecology 29:4, pages 479-488.
Crossref

A. Seroka-Vanhove, C. Sonigo, C. Roche & M. Grynberg. (2014) Quoi de neuf en 2014 sur l’hormone anti-müllérienne ?. Journal de Gynécologie Obstétrique et Biologie de la Reproduction 43:8, pages 559-571.
Crossref

Yangang Huang, Wei Li, Chi Chiu Wang, Xiaoke Wu & Jianhua Zheng. (2014) Cryptotanshinone reverses ovarian insulin resistance in mice through activation of insulin signaling and the regulation of glucose transporters and hormone synthesizing enzymes. Fertility and Sterility 102:2, pages 589-596.e4.
Crossref

Israel Ortega & Antoni J. Duleba. 2014. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome 181 203 .

Sezai Sahmay, Nil Atakul, Begüm Aydogan, Yavuz Aydın, Metehan Imamoglu & Hakan Seyisoglu. (2013) Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome. Acta Obstetricia et Gynecologica Scandinavica 92:12, pages 1369-1374.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Effects of metformin on serum insulin and anti-mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome

Articles from other publishers (19)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Effects of metformin on serum insulin and anti-mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome

Citations (19)

Articles from other publishers (19)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date